June 25, 2020: 25 years of HOPS; successes of San Francisco’s test-and-treat program; missed opportunities to test people who inject drugs; how patient-provider trust can curb prescribing cascades.
The latest update to official guidelines issued by the U.S. Department of Health and Human Services on the treatment and care of people living with HIV occurred within the opportunistic infection guidelines on May 26.
Recent studies examine the role anal sex is playing in HIV rates and anal cancer among women.
Telemedicine is helping keep transgender patients connected to care, but gaps still exist.
Having to diagnose people with HIV again and again can take a mental toll on health care workers, as can hearing people’s traumas. But few health care workers process the vicarious trauma they experience.
April 2, 2020: Physical activity vs. heart med adherence; reducing the burden of HIV emergency care; increasing smoking cessation intervention success; virologic failure following asymptomatic HIV treatment initiation.
Long-Acting Injectable HIV Meds Just as Good as Daily Pill for Newly Diagnosed and Those Already Undetectable
Questions still remain as to when FDA will approve, and how it will be implemented.
A new JAIDS study shows linking to care quickly after diagnosis matters. But there’s more to it.
Reducing the time between contracting HIV and being diagnosed and starting treatment is key to ending the epidemic, this study finds.
The question of whether INSTIs cause weight gain continues to be debated. This story draws together some research on which drugs are associated with weight gain or other metabolic changes.